PI3K: a potential therapeutic target for cancer

Y Chen, BC Wang, Y Xiao - Journal of cellular physiology, 2012 - Wiley Online Library
Abstract Phosphatidylinositol 3‐kinase (PI3K), one member of lipid kinase family, has been
demonstrated to play a key role in regulating cell proliferation, adhesion, survival, and …

[HTML][HTML] PI3K and AKT: unfaithful partners in cancer

S Faes, O Dormond - International journal of molecular sciences, 2015 - mdpi.com
The phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway regulates multiple cellular
processes. An overactivation of the pathway is frequently present in human malignancies …

The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions

MR Khezri, R Jafari, K Yousefi, NM Zolbanin - Experimental and molecular …, 2022 - Elsevier
The human body consists of countless cells with the possibility of excessive and
uncontrolled proliferation under certain dysregulated circumstances that could cause …

[HTML][HTML] Targeting PI3K/Akt signal transduction for cancer therapy

Y He, MM Sun, GG Zhang, J Yang, KS Chen… - Signal transduction and …, 2021 - nature.com
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays a crucial role in various
cellular processes and is aberrantly activated in cancers, contributing to the occurrence and …

[HTML][HTML] Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers

KS Shan, A Bonano-Rios, NWY Theik… - International Journal of …, 2024 - mdpi.com
The dysregulation of the phosphatidylinositol-3-kinase (PI3K) pathway can lead to
uncontrolled cellular growth and tumorigenesis. Targeting PI3K and its downstream …

The PI3K pathway as drug target in human cancer

KD Courtney, RB Corcoran… - Journal of clinical oncology, 2010 - ascopubs.org
The phosphatidylinositol 3-kinase (PI3K) signaling axis impacts on cancer cell growth,
survival, motility, and metabolism. This pathway is activated by several different mechanisms …

[HTML][HTML] Targeting PI3K in cancer: mechanisms and advances in clinical trials

J Yang, J Nie, X Ma, Y Wei, Y Peng, X Wei - Molecular cancer, 2019 - Springer
Abstract Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR)
signaling is one of the most important intracellular pathways, which can be considered as a …

Recent development in targeting PI3K-Akt-mTOR signaling for anticancer therapeutic strategies

A Khurshid Qazi, A Hussain, A Hamid… - Anti-Cancer Agents …, 2013 - ingentaconnect.com
Cancer is a diverse class of diseases which differ widely in their cause and biology. The
aberrant behavior of cancer reflects up regulation of certain oncogenic signaling pathways …

Phosphatidylinositol 3-kinase isoforms as novel drug targets

K Blajecka, A Borgstrom, A Arcaro - Current drug targets, 2011 - ingentaconnect.com
Phosphatidylinositol 3-kinases (PI3Ks) are key molecules in the signal transduction
pathways initiated by the binding of extracellular signals to their cell surface receptors. The …

Advances in the researches on the biological activities and inhibitors of phosphatidylinositol 3-kinase

JF Tang, Q Wen, J Sun, WM Zhang… - Anti-Cancer Agents in …, 2014 - ingentaconnect.com
The PI3K/AKT/mTOR pathway is an intracellular signaling pathway, being important in
apoptosis hence cancer such as breast cancer and non-small-cell lung cancer. It signaling …